18.4001  -0.12 (-0.65%)		04-25 10:54
Open: 18.4 High: 18.49 Volume: 2,745		Pre. Close: 18.52 Low: 18.4 Market Cap: 65(M)

Short term
Mid term
Targets	6-month :	22.47	1-year :	26.24
Resists	First :	19.23	Second :	22.47
Pivot price	18.39
Supports	First :	17.77	Second :	16.87
MAs	MA(5) :	18.7	MA(20) :	18.22
	MA(100) :	18.3	MA(250) :	17.68
MACD	MACD :	0.2	Signal :	0.2
%K %D	K(14,3) :	64.6	D(3) :	70.9
RSI	RSI(14): 53.5
52-week	High :	22.98	Low :	14.51

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ PDEX ] has closed below upper band by 42.7%. Bollinger Bands are 49.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	19 - 19.09	19.09 - 19.18
Low:	18.22 - 18.32	18.32 - 18.42
Close:	18.58 - 18.74	18.74 - 18.89

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Tue, 23 Apr 2024
(PDEX) Technical Pivots with Risk Controls - Stock Traders Daily

Sat, 13 Apr 2024
Short Interest in Pro-Dex, Inc. (NASDAQ:PDEX) Declines By 20.4% - MarketBeat

Thu, 08 Feb 2024
Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results - Yahoo Finance

Sun, 17 Dec 2023
3 Very Undervalued Stocks With Strong Growth Prospects - InvestorPlace

Mon, 13 Nov 2023
Here's Why You Should Consider Buying Pro-Dex (PDEX) Shares - Yahoo Finance

Wed, 01 Nov 2023
News – Stock Day Media - Stock Day Media

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	4 (M)
Shares Float	2 (M)
Held by Insiders	32.8 (%)
Held by Institutions	25.7 (%)
Shares Short	15 (K)
Shares Short P.Month	14 (K)

EPS	0.83
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	8.97
Profit Margin	6.2 %
Operating Margin	6.1 %
Return on Assets (ttm)	7.9 %
Return on Equity (ttm)	10.6 %
Qtrly Rev. Growth	11.6 %
Gross Profit (p.s.)	0
Sales Per Share	13.74
EBITDA (p.s.)	2.08
Qtrly Earnings Growth	-81.4 %
Operating Cash Flow	4 (M)
Levered Free Cash Flow	2 (M)

PE Ratio	22.02
PEG Ratio	0
Price to Book value	2.06
Price to Sales	1.34
Price to Cash Flow	15.95

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.